Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neurocognitive Dysfunction: early-phase trial registry
4 of 7 indexed Neurocognitive Dysfunction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Neurocognitive Dysfunction: 7 US clinical trials tracked, 4 recruiting.
Neurocognitive Dysfunction is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Diego, running 2 of these trials.
Enrollment posture brief
Registry condition neurocognitive-dysfunction
OPEN 4 | RECR 57% | LATE 0 | EARLY 2 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Neurocognitive Dysfunction lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neurocognitive Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neurocognitive Dysfunction is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neurocognitive Dysfunction research.
University of California, San Diego accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Neurocognitive Dysfunction enrolment sits around 100 participants.
Median target enrolment is 100 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Neurocognitive Dysfunction splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
United States Naval Medical Center, San Diego
NCT06413173
Ca-Mg Butyrate in GWI
VA Office of Research and Development
NCT05367245
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Mclean Hospital
NCT05245903
Assessing Neurocognition After Cerebrovascular Intervention
University of California, San Diego
NCT03344276
Long Term Follow up of Children Enrolled in the REDvent Study
Children's Hospital Los Angeles
NCT03709199
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
HealthPartners Institute
NCT02992327
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
University of California, San Diego
NCT03368352
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neurocognitive Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neurocognitive Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neurocognitive Dysfunction page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Neurocognitive Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, San Diego sponsors the most Neurocognitive Dysfunction trials on record, review their full trial history before evaluating a specific study. See University of California, San Diego's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurocognitive Dysfunction condition card totals 7 registered trials; most-linked intervention Hypoxia; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.